NEW YORK (GenomeWeb) – Invitae today announced that it is expecting revenues of more than $144 million in 2018, more than double the revenue it generated in 2017.

As part of a preliminary financials report, the company said it doubled testing volume year over year to more than 302,000 samples compared to around 150,000 in 2017. The revenue projections are approximately $2 million above consensus Wall Street estimates, and testing volume exceeds the company's own prior guidance of 285,000 samples.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.